NSE filing, NSE: NUCLEUS. Summary written from the filing by ALFA Finder's alert engine.
Nucleus Software Exports Ltd: key numbers
- Share price
- ₹664.85
- Market cap
- ₹1,750 Cr
- Revenue (annual)
- ₹876.0 Cr
- Net profit (annual)
- ₹116.7 Cr
- P/E (TTM)
- 16.6×Sector 22.9×
- Promoter holding
- 73.60%+0.00% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nucleus Software Exports Ltd
All →Nucleus Software Exports Board Meeting Date
Nucleus Software Exports has scheduled a Board Meeting on 31 October 2026 to approve standalone and consolidated financial results for Q1/H1 FY27. No figures are disclosed in this advance notice.
Nucleus Software Exports Business Update
Nucleus Software won the 'Most Innovative Practice' award at the 3rd CII National AI Awards 2026. The recognition highlights its Generative AI-powered Visual Report Agent for personalized financial communication.
Nucleus Software Exports Other Announcement
Nucleus Software Exports Limited has filed the mandatory quarterly certificate from its Registrar and Share Transfer Agent, KFin Technologies Limited, under SEBI Regulation 74(5).
Nucleus Software Exports Legal & Regulatory
Nucleus Software received a GST show cause notice from the UP State Tax Department demanding ₹17.49 Crore, including interest and penalties, for FY 2022-23.
- Value
- ₹17.49 Cr
- From
- State Tax Deputy Commissioner, Gautambuddha Nagar
Nucleus Software Exports Management Change
Nucleus Software Exports appointed Mr. Sudhanshu Tripathi as Chief Marketing Officer effective September 21, 2026. He brings over two decades of technology-marketing leadership experience.
Nucleus Software Exports Other Announcement
Nucleus Software Exports Ltd has amended its Code of Conduct for Prevention of Insider Trading to align with SEBI regulations. This is a routine compliance update.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date